As of Mar 24
| +0.15 / +1.15%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 19.00, with a high estimate of 19.00 and a low estimate of 18.00. The median estimate represents a +43.83% increase from the last price of 13.21.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.